Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Shum

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Journal of Medical Systems|March 10, 2026
Machine Learning-Driven Prediction of Intensive Care Units Mortality and Length of Stay: A 11-Year Retrospective Study in Hong Kong Public HospitalsYing Zhao, Xincheng Shu, Chi-Sing Leung, et al.
Light, Science & Applications|February 19, 2024
RSPSSL: A novel high-fidelity Raman spectral preprocessing scheme to enhance biomedical applications and chemical resolution visualizationJiaqi Hu, Gina Jinna Chen, Chenlong Xue, et al.
Thorax|August 18, 2022
Population study on diagnosis, treatment and outcomes of critically ill patients with tuberculosis (2008-2018)Christina So, Lowell Ling, Wai Tat Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2022
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled TrialAnthony Raymond Tam, Ricky Ruiqi Zhang, Kwok-Cheung Lung, et al.
Journal of Intensive Care|January 7, 2021
Characteristics and outcomes of patients admitted to adult intensive care units in Hong Kong: a population retrospective cohort study from 2008 to 2018Lowell Ling, Chun Ming Ho, Pauline Yeung Ng, et al.
Lancet (London, England)|May 14, 2020
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Journal of Medical Systems|March 10, 2026
Machine Learning-Driven Prediction of Intensive Care Units Mortality and Length of Stay: A 11-Year Retrospective Study in Hong Kong Public HospitalsYing Zhao, Xincheng Shu, Chi-Sing Leung, et al.
Light, Science & Applications|February 19, 2024
RSPSSL: A novel high-fidelity Raman spectral preprocessing scheme to enhance biomedical applications and chemical resolution visualizationJiaqi Hu, Gina Jinna Chen, Chenlong Xue, et al.
Thorax|August 18, 2022
Population study on diagnosis, treatment and outcomes of critically ill patients with tuberculosis (2008-2018)Christina So, Lowell Ling, Wai Tat Wong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2022
Early Treatment of High-Risk Hospitalized Coronavirus Disease 2019 (COVID-19) Patients With a Combination of Interferon Beta-1b and Remdesivir: A Phase 2 Open-label Randomized Controlled TrialAnthony Raymond Tam, Ricky Ruiqi Zhang, Kwok-Cheung Lung, et al.
Journal of Intensive Care|January 7, 2021
Characteristics and outcomes of patients admitted to adult intensive care units in Hong Kong: a population retrospective cohort study from 2008 to 2018Lowell Ling, Chun Ming Ho, Pauline Yeung Ng, et al.
Lancet (London, England)|May 14, 2020
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trialIvan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso, et al.
Pageof 26